Evidence map›Paper›PMID 39512837›Full record

ArticleFASEB bioAdvances2024

Mitochondrial functional impairment in

Xiaoli Zhang, Shun Yao, Lujia Zhang, Beisi Zhang, Mingzhu Yang, Qingge Guo, Jin Xu, Zhongfeng Wang, Bo Lei, Xiuxiu Jin

Abstract read
In one paragraph

Article in FASEB bioAdvances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. A Novel HeterozygousInternational journal of molecular sciences · 2026
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xiaoli ZhangInstitute of Neuroscience and The Third Affiliated Hospital of Zhengzhou University Zhengzhou China.
Shun YaoHenan Eye Institute, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital Zhengzhou China.
Lujia ZhangInstitute of Neuroscience and The Third Affiliated Hospital of Zhengzhou University Zhengzhou China.
Beisi ZhangHenan Eye Institute, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital Zhengzhou China.
Mingzhu YangHenan Eye Institute, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital Zhengzhou China.
Qingge GuoHenan Eye Institute, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital Zhengzhou China.
Jin XuHenan Eye Institute, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital Zhengzhou China.
Zhongfeng WangInstitute of Neuroscience and The Third Affiliated Hospital of Zhengzhou University Zhengzhou China.
Bo LeiHenan Eye Institute, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital Zhengzhou China.ORCID https://orcid.org/0000-0002-5497-0905
Xiuxiu JinInstitute of Neuroscience and The Third Affiliated Hospital of Zhengzhou University Zhengzhou China.ORCID https://orcid.org/0000-0003-2978-303X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitochondria are vital for retinal cell function and survival, and there is growing evidence linking mitochondrial dysfunction to retinal degenerations. Although

Indexed as

apoptosisARL3mitochondriamutationrod‐cone dystrophy

Identifiers

PMID39512837
PMCPMC11539027

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.